Your browser doesn't support javascript.
loading
Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial.
Nooka, Ajay K; Cohen, Adam D; Lee, Hans C; Badros, Ashraf; Suvannasankha, Attaya; Callander, Natalie; Abdallah, Al-Ola; Trudel, Suzanne; Chari, Ajai; Libby, Edward N; Chaudhry, Maria; Hultcrantz, Malin; Kortüm, K Martin; Popat, Rakesh; Sborov, Douglas; Hakim, Shawn; Lewis, Eric; Gorsh, Boris; Bhushan, Bharat; McKeown, Astrid; Gupta, Ira; Opalinska, Joanna; Richardson, Paul G; Lonial, Sagar.
Afiliación
  • Nooka AK; Winship Cancer Institute, Emory University Hospital, Atlanta, Georgia, USA.
  • Cohen AD; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Lee HC; MD Anderson Cancer Center, Houston, Texas, USA.
  • Badros A; University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Suvannasankha A; Indiana University Simon Cancer Center and Roudebush VAMC, Indianapolis, Indiana, USA.
  • Callander N; Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin, USA.
  • Abdallah AO; University of Kansas, Kansas City, Kansas, USA.
  • Trudel S; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Chari A; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Libby EN; Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Chaudhry M; George Washington University, Washington, DC, USA.
  • Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Kortüm KM; Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany.
  • Popat R; University College London Hospitals, NHS Foundation Trust, London, UK.
  • Sborov D; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Hakim S; GSK, Upper Providence, Pennsylvania, USA.
  • Lewis E; GSK, Research Triangle Park, North Carolina, USA.
  • Gorsh B; GSK, Upper Providence, Pennsylvania, USA.
  • Bhushan B; GSK, Bangalore, India.
  • McKeown A; GSK, Stevenage, UK.
  • Gupta I; GSK, Research Triangle Park, North Carolina, USA.
  • Opalinska J; GSK, Upper Providence, Pennsylvania, USA.
  • Richardson PG; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Lonial S; Winship Cancer Institute, Emory University Hospital, Atlanta, Georgia, USA.
Cancer ; 129(23): 3746-3760, 2023 12 01.
Article en En | MEDLINE | ID: mdl-37622738
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Revista: Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Revista: Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos